Oita, Japan

Yoichi Akiyama

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1990.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoichi Akiyama: Innovator in Pharmaceutical Compounds

Introduction

Yoichi Akiyama is a notable inventor based in Oita, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on thienotriazolodiazepine compounds. His research focuses on compounds that exhibit PAF-antagonistic activity, which are useful in the prevention and treatment of various PAF-induced diseases.

Latest Patents

Akiyama holds a patent for thienotriazolodiazepine compounds and their pharmaceutical uses. The patent describes a thienotriazolodiazepine compound of a specific formula, or a pharmaceutically acceptable acid addition salt thereof. This invention highlights the potential of these compounds in addressing critical health issues related to PAF-induced diseases.

Career Highlights

Yoichi Akiyama is associated with Yoshitomi Pharmaceutical Industries, Ltd., where he has been instrumental in advancing pharmaceutical research. His work has led to the development of innovative solutions that contribute to better healthcare outcomes.

Collaborations

Akiyama has collaborated with notable colleagues such as Kenichi Demizu and Minoru Moriwaki. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

In summary, Yoichi Akiyama is a distinguished inventor whose work in thienotriazolodiazepine compounds has the potential to significantly impact the pharmaceutical industry. His contributions reflect a commitment to advancing medical science and improving patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…